MAI Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,018
| Closed | -$647 | – | 3442 |
|
|
2024
Q4 | $647 | Buy |
+4,018
| New | +$647 | ﹤0.01% | 3103 |
|
|
2024
Q3 | – | Sell |
-27,417
| Closed | -$14.9K | – | 1215 |
|
|
2024
Q2 | $14.9K | Sell |
27,417
-336,680
| -92% | -$183K | ﹤0.01% | 1187 |
|
|
2024
Q1 | $371K | Buy |
364,097
+8,637
| +2% | +$8.81K | ﹤0.01% | 873 |
|
|
2023
Q4 | $203K | Sell |
355,460
-42,210
| -11% | -$24.1K | ﹤0.01% | 995 |
|
|
2023
Q3 | $414K | Buy |
397,670
+90,100
| +29% | +$93.7K | 0.01% | 683 |
|
|
2023
Q2 | $434K | Sell |
307,570
-71,898
| -19% | -$101K | 0.01% | 683 |
|
|
2023
Q1 | $603K | Sell |
379,468
-47,448
| -11% | -$75.4K | 0.01% | 559 |
|
|
2022
Q4 | $623K | Sell |
426,916
-210,725
| -33% | -$308K | 0.01% | 534 |
|
|
2022
Q3 | $2.72M | Sell |
637,641
-10,309
| -2% | -$44K | 0.05% | 217 |
|
|
2022
Q2 | $2.51M | Buy |
647,950
+267,162
| +70% | +$1.04M | 0.05% | 219 |
|
|
2022
Q1 | $1.81M | Buy |
+380,788
| New | +$1.81M | 0.03% | 277 |
|